- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Option Bulls Take Another Shot on Idenix
- Top 20 European Stocks for Crisis Time: Strategist
- Hewlett-Packard Faces a ‘Dogfight’ for Talent: Analyst
- DuckDuckGo Cooks Google’s Goose: Analyst
- General Electric’s $4.5 Billion Dividend Slated for Buybacks
ABOUT THE CNBC STOCK BLOG
ART CASHIN
RSS FEED
CNBC Stock Blog
Text Size 
Giving the Grade to Five Popular Stocks
Some stocks are more popular than others. But that doesn't mean they're always the best shares to hold. Michael Farr, president of Farr, Miller and Washington, gave his assessment of five of the most widely held companies.
General Electric [GE
Loading...
()
]—“I have liked General Electric for a long time. I have owned it at much higher levels and continue to own it at much higher levels. I think they have been in the best position than all the other financials at eleven times earnings. I think growth will continue at around 11 percent, 6 1/4 percent dividend.”
(See the accompanying video for Farr's full take on these five stocks.)
Exxon [XOM
Loading...
()
]—“Exxon is probably the best in class of the oils. Eight percent earnings growth, around a two, two and a quarter percent in the dividend. The best return on capital, most stable track record...Probably won’t be a hot stock but will be a safe stock.”
Microsoft [MSFT
Loading...
()
]—"Microsoft in particular, looks to me fairly inexpensive. At eleven times earnings, with a huge amount of cash on the balance sheet, no real need to access capital markets. Ten percent earnings growth, I think it probably makes sense.”
Wal Mart [WMT
Loading...
()
]—"Wal Mart’s done very well, I just think it’s too expensive at these levels. We have seen a great trade depth, consumers that were buying at higher end retailers are all going to Wal Mart now. Wal Mart’s numbers look pretty good but at 15 1/2 times while the consumer is still shrinking and feeling pressure, and housing prices are still dropping, I’d like to buy it a little cheaper.”
Pfizer [PFE
Loading...
()
]—"My least favorite of the five. Lipitor is coming off patent here, their going to loose 25 percent of their revenue coming up. Pfizer certainly look’s pretty cheap at 7 ½ times earnings but I’m only seeing projected earning growth of about 2 percent.”
Disclosure:
Disclosure information on Farr's stock holdings was not available.
Data is a real-time snapshot *Data is delayed at least 15 minutes
